Abstract | RATIONALE: PATIENT CONCERNS: We present a 68-year-old woman with acute symptoms of PCD as a first sign of underlying occult malignancy. Further investigation revealed a positive anti-Yo antibody. Although brain magnetic resonance imaging (MRI) was unremarkable, positron emission tomography (PET)/computed tomography (CT) revealed intense hypermetabolism of cerebellum and diffused hypometabolism in the rest of brain. On 1-year follow-up, despite the primary malignancy is still unknown, her symptoms improved significantly after immunotherapy. DIAGNOSES: INTERVENTIONS: The patient was given IV methylprednisolone 500 mg once a day for 5 consecutive days, followed by oral prednisone 60 mg once a day for 3 months. OUTCOMES: The patient's symptoms were gradually improved during the hospitalization period. On one year follow up, she was able to walk independently and perform some simple tasks. LESSONS: Cerebellar hypermetabolism in PCD suspected patients may help confirming the diagnosis in an earlier stage and may predict a better outcome after immunotherapy.
|
Authors | Ammar Taha Abdullah Abdulaziz, Xiao Qing Yu, Le Zhang, Xin Yue Jiang, Dong Zhou, Jin Mei Li |
Journal | Medicine
(Medicine (Baltimore))
Vol. 97
Issue 24
Pg. e10717
(Jun 2018)
ISSN: 1536-5964 [Electronic] United States |
PMID | 29901574
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- CDR2 protein, human
- Glucocorticoids
- Nerve Tissue Proteins
|
Topics |
- Aged
- Cerebellum
(diagnostic imaging, pathology)
- Female
- Glucocorticoids
(therapeutic use)
- Humans
- Immunotherapy
(methods)
- Neoplasms, Unknown Primary
(complications, diagnostic imaging)
- Nerve Tissue Proteins
(immunology)
- Paraneoplastic Cerebellar Degeneration
(diagnosis, pathology, therapy)
- Positron Emission Tomography Computed Tomography
(methods)
|